Avepoint, INC Form 4 insider transactions
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Gong Xunkai, disposed of 6,117 shares of common stock at $10.3 per share to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, received significant performance-based equity awards and stock options, aligning incentives with future company growth.
NASDAQ
AVPT
Avepoint, INCAvePoint's CEO, Tianyi Jiang, was granted 147,338 performance-based restricted stock units and 252,609 stock options, linking executive compensation to future growth and profitability targets.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Financial Officer, James Caci, was granted significant restricted stock units and performance-based equity awards.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, increased his beneficial ownership through new RSU and PRSU grants and the exercise of stock options.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, reported a non-discretionary disposition of 3,988 shares for tax withholding purposes related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO Jiang Tianyi reported a non-discretionary disposition of 2,914 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Financial Officer, James Caci, disposed of shares to cover tax obligations related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, reported the disposition of 12,509 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, reported a non-discretionary disposition of 322 common shares for tax withholding purposes.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, sold 60,000 shares of common stock for approximately $812,200 under a pre-arranged 10b5-1 trading plan.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, acquired 928 Restricted Stock Units on December 30, 2025, as part of an equity incentive plan termination.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, reported the disposition of 1,547 common shares to cover tax liabilities related to vested restricted stock units.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Financial Officer, James Caci, reported a non-discretionary disposition of 2,823 common shares to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint, Inc. Executive Chairman Xunkai Gong reported a routine disposition of 6,500 shares of common stock for tax withholding purposes related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's CEO, Tianyi Jiang, reported a non-discretionary disposition of common stock to cover tax liabilities from RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, reported stock option exercises and tax-related share dispositions on December 12, 2025.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Financial Officer, James Caci, reported a disposition of 6,120 shares of common stock to cover tax liabilities related to the vesting of restricted stock units.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO Tianyi Jiang reported a non-discretionary disposition of 2,914 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, disposed of 4,025 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, reported sales of common stock totaling 60,000 shares under a pre-arranged 10b5-1 trading plan.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Financial Officer, James Caci, reported a non-discretionary sale of 3,957 shares of common stock to cover tax obligations related to security vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, disposed of 2,835 shares of common stock to cover tax liabilities related to RSU vesting.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, reported the sale of 60,000 shares of common stock through a pre-arranged 10b5-1 trading plan.
NASDAQ
AVPT
Avepoint, INCAvePoint's Chief Legal Officer, Brian Michael Brown, sold 1,848 shares of common stock for $15.03 per share on October 24, 2025, under a Rule 10b5-1 plan.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO Jiang Tianyi exercised stock options to acquire 496,043 shares of common stock at $14.08 per share on October 17, 2025, significantly increasing direct ownership.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO and Director Jiang Tianyi amended a Form 4 to report the exercise of over 2.6 million stock options.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO Tianyi Jiang transferred 1.54 million shares valued at $22.5 million from direct to indirect ownership to repay a loan.
NASDAQ
AVPT
Avepoint, INCAvePoint CEO Tianyi Jiang exercised stock options to acquire over 2.6 million shares of common stock at $14.61 per share, significantly increasing direct beneficial ownership.
NASDAQ
AVPT
Avepoint, INCAvePoint's Executive Chairman, Xunkai Gong, sold 60,000 shares of common stock in early October 2025 through a pre-arranged Rule 10b5-1 trading plan.